Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL69834 | 0.83 | EPHX2 (0.33) | EPHX2 | |
| SCHEMBL2221781 | 0.81 | GAA (0.35) | EPHX2 | |
| SCHEMBL7931906 | 0.80 | EPHX2 (0.31) | EPHX2 | |
| SCHEMBL9591759 | 0.80 | EPHX2 (0.31) | EPHX2 | |
| SCHEMBL25701611 | 0.80 | EPHX2 (0.31) | EPHX2 | |
| SCHEMBL9008839 | 0.80 | EPHX2 (0.37) | EPHX2ALDH1A1 | |
| SCHEMBL1150230 | 0.76 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL8620992 | 0.76 | EPHX2 (0.32) | EPHX2 | |
| SCHEMBL11173686 | 0.75 | EPHX2 (0.32) | EPHX2 | |
| SCHEMBL25700486 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3436520-B1 | CROSSLINKABLE POLYMERIC COMPOSITIONS WITH METHYL-RADICAL SCAVENGERS AND ARTICLES MADE THEREFROM | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-10-04 | — | — | EP | claimed |
| EP-3436527-B1 | CROSSLINKABLE POLYMERIC COMPOSITIONS WITH METHYL-RADICAL SCAVENGERS AND ARTICLES MADE THEREFROM | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-09-06 | — | — | EP | claimed |
| CN-108884280-B | Crosslinkable polymeric compositions with methyl scavengers and articles made therefrom | 陶氏环球技术有限责任公司 | 2022-01-14 | — | — | CN | claimed |
| US-10851221-B2 | Crosslinkable polymeric compositions with methyl-radical scavengers and articles made therefrom | DOW GLOBAL TECHNOLOGIES LLC (US) | 2020-12-01 | — | — | US | claimed |
| US-20200299483-A1 | Crosslinkable Polymeric Compositions with Methyl-Radical Scavengers and Articles Made Therefrom | DOW GLOBAL TECHNOLOGIES LLC | 2020-09-24 | — | — | US | claimed |
| US-20190106557-A1 | CROSSLINKABLE POLYMERIC COMPOSITIONS WITH METHYL-RADICAL SCAVENGERS AND ARTICLES MADE THEREFROM | DOW GLOBAL TECHNOLOGIES LLC (US) | 2019-04-11 | — | — | US | claimed |
| EP-2125939-B1 | SOCYANATE AND DIISOCYANATE COMPOUNDS FOR MINIMIZING SCORCH AND DIISOCYANATE COMPOUNDS FOR PROMOTING CURE IN CROSSLINKABLE COMPOSITIONS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2011-09-21 | — | — | EP | claimed |
| EP-3615608-B1 | POLYETHYLENE BLEND COMPOSITION | DOW GLOBAL TECHNOLOGIES LLC (US) | 2024-07-17 | — | — | EP | disclosed |
| EP-4381010-A1 | POLYOLEFIN FORMULATION CONTAINING COMBINATION OF VOLTAGE STABILIZER COMPOUNDS | Dow Global Technologies LLC (US) | 2024-06-12 | — | — | EP | disclosed |
| EP-4381009-A1 | POLYOLEFIN FORMULATION CONTAINING COMBINATION OF VOLTAGE STABILIZER COMPOUNDS | Dow Global Technologies LLC (US) | 2024-06-12 | — | — | EP | disclosed |
| EP-4381011-A1 | POLYOLEFIN FORMULATION CONTAINING CROTOPHENONE COMPOUND | Dow Global Technologies LLC (US) | 2024-06-12 | — | — | EP | disclosed |
| EP-4077496-B1 | POLYOLEFIN COMPOSITION | DOW GLOBAL TECHNOLOGIES LLC (US) | 2024-04-17 | — | — | EP | disclosed |
| EP-3436520-B1 | CROSSLINKABLE POLYMERIC COMPOSITIONS WITH METHYL-RADICAL SCAVENGERS AND ARTICLES MADE THEREFROM | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-10-04 | — | — | EP | disclosed |
| WO-2018102242-A1 | PEROXIDE-CURABLE POLYOLEFIN COMPOSITION | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-06-07 | — | — | WO | disclosed |
| WO-2017166105-A1 | CROSSLINKABLE POLYMERIC COMPOSITIONS WITH METHYL-RADICAL SCAVENGERS AND ARTICLES MADE THEREFROM | DOW GLOBAL TECHNOLOGIES LLC (US) | 2017-10-05 | — | — | WO | disclosed |
| CN-102001993-A | Preparation method of polymerization inhibitor (4-allyloxy-2,2,6,6- tetramethyl-piperidinooxy) | NANTONG HICON INTERNAT ENTPR CO LTD | 2011-04-06 | — | — | CN | disclosed |
| CN-102001993-A | Preparation method of polymerization inhibitor (4-allyloxy-2,2,6,6- tetramethyl-piperidinooxy) | NANTONG HICON INTERNAT ENTPR CO LTD | 2011-04-06 | — | — | CN | disclosed |
| US-20100168434-A1 | INHIBITION OF POLYMERISATION | A H MARKS AND COMPANY LIMITED (GB) | 2010-07-01 | — | — | US | disclosed |
| EP-1937726-A1 | INHIBITION OF POLYMERISATION | A H Marks & Company Limited (GB) | 2008-07-02 | — | — | EP | disclosed |
| WO-2007045886-A1 | INHIBITION OF POLYMERISATION | A H MARKS AND COMPANY LIMITED (GB) | 2007-04-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100168434-A1 | INHIBITION OF POLYMERISATION | NOS2, NOS1, NOS3 | EPHX2 159/4885ALDH1A1 744/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.